Bausch + Lomb (BLCO)

• Market cap: $5.63B
• 1 day: -0.88%
• 5 days: -1.68%
• 1 month: -0.63%
• 3 months: -14.66%
• 6 months: -2.59%
• Year to date: -4.83%
• 1 year: 33.73%
• 5 years: -21.1%
• 10 years: -21.1%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Employees: 13,000